A fundus camera is a specialized low power microscope with an attached high resolution camera. Its optical design is based on the indirect ophthalmoscope. Fundus cameras are used to diagnose various types of retinal disorders. The factors that propel the growth of the global Fundus Cameras market research report include growing occurrence of retinal disorders, rise in geriatric population, and advancement in technologies. In addition, availability of advanced fundus optical devices such as hybrid cameras with multiple functionalities is significantly fuelling the growth of the market.
Moreover, the growing applications of fundus cameras in diagnosing a range of retinal disorders at an early stage have boosted the demand for portable and high-performing fundus devices. On the other hand, there are also factors that hamper the growth of the market such as high cost related with integrating advanced technology features in fundus cameras. The global Fundus Cameras market research report is classified on the basis of product type, end users and geography. On the basis of product type, the global Fundus Cameras market research report is classified as Mydriatic Fundus Cameras, Non Retractable Fundus Cameras, Hybrid Fundus Cameras and Retinopathy of Prematurity (ROP) Fundus Cameras. The Mydriatic Fundus Cameras is further sub classified as Tabletop and Handheld. The Non Retractable Fundus Cameras is further sub classified as Tabletop and Handheld. Browse Deatils of Report @ https://www.hexaresearch.com/research-report/fundus-cameras-market Among the product type, Non-mydriatic fundus cameras segment is projected to account a major share of the global Fundus Cameras market research report. The key factor that drives the growth of this segment is because this device can be used for screening of glaucoma patients and those sensitive to light. Whereas, the Hybrid Fundus Cameras is expected to grow at the highest growth rates in the global Fundus Cameras market research report. The key factor that drives the growth of this segment is owed to availability of a combination of technologies in a single device. Some of the hybrid fundus cameras commercially available include VX-20 by Kowa Optimed, Inc., CX-1 by Canon, Inc., and iFusion by Optovue, Inc. In addition, these devices are easier to use and more reliable for diagnosis of vision-threatening diseases. On the basis of end users, the global Fundus Cameras market research report is classified as hospitals, ophthalmology clinics and ophthalmic and optometrist offices. Among the end users, ophthalmic and optometrist offices segment id projected to account a major share of the global Fundus Cameras market research report. The major share of this segment is owed to increase in the number of specialty clinics and high preference for optometrists for primary eye care. On the basis of geography, the global Fundus Cameras market research report is classified as North America, Europe, Asia Pacific, Latin America, and Rest of the World. The North American region consists of the U.S. and Canada. The European region consists of England, Germany and Rest of Europe. Asia Pacific region consists of Australia, Japan and Rest of Asia Pacific. Latin America region consists of Brazil and Rest of Latin America. In case of geographical region, North America is projected to account a major share of the global Fundus Cameras market research report. The factors that attribute to the growth of North America is due to rising awareness about eye disorders, increased healthcare expenditure, technological advancements and well established healthcare infrastructure and facilities. In addition, government support for reimbursement & screening of devices significantly fuel the growth of the market. Europe is also projected to show significant growth rates in the global Fundus Cameras market research report. On the other hand, Asia Pacific is anticipated to be the most lucrative region in the upcoming years owing to growing medical tourism and increasing awareness of retinal and ocular diseases. Also, growing awareness of treating diabetic retinopathy at an early stage in countries such as India and Japan is expected to boost the growth of this region. Furthermore, investment by the governments of several countries in Asia Pacific to develop healthcare infrastructure is considerably fuelling the growth of the market. Some of the prominent players that fuel the growth of the global Fundus Cameras market research report include Topcon Corporation, Canon, Inc., Nidek Co., Ltd., Optovue, Inc., CenterVue S.p.A., Carl Zeiss Meditec AG, Kowa Optimed, Inc., Optomed Oy (Ltd.), and Clarity Medical Systems. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit our Blog: hexaresearch1.blogspot.com
0 Comments
Factors that propel the global Autoimmune Disease Diagnostics Market are rising cases of autoimmune diseases and surging healthcare expenditure. Encouraging governmental policies regarding autoimmune diagnostics & research has a positive impact on market demand. Autoimmune diseases are a key cause of women deaths worldwide. Furthermore, active awareness initiatives regarding diagnosis of diseases may contribute significantly to the global industry during the forecast period (2012 to 2020). A large number of laboratories have begun installing equipment that can carry out several tests simultaneously and deliver quick results. Automation in laboratory procedures ensures greater efficiency.
The worldwide autoimmune disease diagnostics market is categorized on the basis of products and regions. On the basis of products, there are two key segments, namely, localized disease diagnostics and systemic autoimmune disease diagnostics. Owing to greater patient awareness and huge procedure volumes, the localized disease diagnostics segment held the highest share in 2013. A number of unmet medical needs in type 1 diabetics is a key factor that drives this segment. The systemic autoimmune disease diagnostics segment mainly involves the diagnosis of diseases, such as rheumatoid arthritis, lupus erythematosus (SLE), and Ankylosing spondylitis. The rheumatoid arthritis segment holds the highest share in the industry because it is the most frequently occurring inflammatory ailment worldwide. It is led by product innovation. Browse Details of Report @ https://www.hexaresearch.com/research-report/autoimmune-disease-diagnostics-industry On the basis of geographies, the global autoimmune disease diagnostics market is divided into Europe, Asia Pacific, North America, and Rest of the World. In revenue terms, North America was the largest market in 2013. This region is propelled by a well developed healthcare infrastructure and positive government initiatives, such as the Affordable Care Act and Patient Protection Act. In terms of yearly expenditure on autoimmune disease diagnostics, North America ranks number one in the overall industry. Moreover, surging per capita spending on healthcare is projected to significantly drive regional growth till 2020. Europe, the second largest market after North America, is propelled by technological advancements and high cases of autoimmune diseases. These technological developments are mainly observed in portable diagnostics equipment and biomarkers. Europe may derive much of its demand for autoimmune disease diagnostics from Eastern Europe. Being a highly consolidated one, the global market for autoimmune disease diagnostics market witnesses frequent mergers & acquisitions. It is a moderately competitive industry that is led by innovations and price wars. Key competitors in the global industry are Bio Rad, Crescendo Bioscience, Roche Diagnostics, Quest Diagnostics, and Abbott Diagnostics. In October 2016, IQuity, a diagnostics technology company launched the IQIsolate® technology. This technology helps identify autoimmune anomalies during its early stages. It analyzes the RNA structures in blood samples. Interestingly, IQIsolate® has exhibited ninety percent accuracy in three key medical specialties, namely, rheumatology, gastroenterology, and neurology. The company asserts that its technology can significantly reduce the diagnostics processes of complex autoimmune diseases. It can also differentiate between diseases that show similar symptoms. A striking feature of IQuity’s blood based diagnostic technology is that it helps providers & physicians confirm other types of autoimmune anomalies within a week. It is expected to gradually commercialize newer test panels that focus on rheumatology and gastroenterology. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit Our Blog: hexaresearch1.blogspot.com The global Genomics Market is propelled by the introduction of novel technologies that utilize genomic information in disease research. It helps researchers comprehend the genetic bases of drug responses & diseases. Favorable government reimbursement policies coupled with high incidence of lifestyle diseases, such as diabetes & cancer and are key industry drivers. Popularity of genome profiling technologies and widespread use of innovative genomics tools & techniques can fuel market demand over the forecast period (2016 - 2024).
Genomics is that aspect of biology that deals with bioinformatics, DNA, and DNA sequencing to analyze, assemble, and sequence the structure & function of genomes. Genomes refer to the entire DNA set in a single cell of an organism. The worldwide Genomics Market is systematically categorized on the basis of products, applications, technologies, and regions. Instruments, services, and consumables are the three key product segments. With a nearly 60% share, consumables dominated the industry in 2013. This segment is expected to grow at a CAGR surpassing 11% during the forecast period. Popularity of genomic testing in a host of commercial applications is a key driver of this segment. Browse Details of Report @ https://www.hexaresearch.com/research-report/genomics-industry On the basis of applications, the global genomics industry is divided into academic research, drug discovery, diagnostics, personalized medicine, and others. Diagnostics held the highest market share in 2013. Preference for molecular diagnostics tests and awareness among medical practitioners about the advantages of genetic-based diagnostics are factors that propel this segment. It is expected that personalized medicine will register a high growth rate throughout the forecast period. Treatment optimization, affordable treatments, patient compliance, early disease prognosis, and drug safety are vital drivers of this segment. North America emerged a global leader in the market for personalized medicine in 2013. This was due to progress in the world of genetics and robust technological developments. As per technologies, the industry is segmented as DNA microarray, nucleic acid extraction & purification, PCR (polymerase chain reaction), and DNA sequencing. PCR led the market in 2013 due to factors, such as R&D in genomics & proteomics, encouraging government policies on R&D funding, and technological advancements. Ongoing industry trends suggest that the nucleic acid extraction & purification segment may grow at a CAGR exceeding 10% till 2024. Europe, Asia Pacific, North America, and Rest of the World are the four regional segments of the global Genomics Industry. Prevalence of cardiovascular & genetic disorders and high investments in genomics & proteomics drive the Europe genomics market. This region held the largest industry share in 2013. However, volatile economic conditions and uneven reimbursement policies may hamper regional growth in the forthcoming years. Asia Pacific is expected to grow rapidly over the forecast period because of widespread adoption of genomics techniques in emerging countries, such as China and India. These regions utilize genomics technologies to diagnose & treat diseases, like cancer and diabetes. Other factors that fuel the Asia Pacific region are surging medical expenditure, high disposable incomes, and better healthcare infrastructure. Key players in the global genomics market are Life Technologies, Roche Diagnostics, GE Healthcare, Agilent Technologies, and Cepheid. Researchers have developed a microscope that uses a cell phone camera for detecting fluorescent components of DNA sequencing responses in tissues & cells. This special device can identify point mutations in KRAS genes. The KRAS gene is found in more than thirty percent of colon cancers. A number of sequencing techniques are used to fluorescently label & amplify copies of the target DNA transcript or sequence. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/biotechnology-industry About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: [email protected] Website - http://www.hexaresearch.com/ Visit our Blog: hexaresearch1.blogspot.com |
Archives
October 2023
|